Adverum Biotechnologies (ADVM) Misses Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts ADVM Hot Sheet
Join SI Premium – FREE
Adverum Biotechnologies (NASDAQ: ADVM) reported Q3 EPS of ($0.40), $0.05 worse than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
- Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
